James A. Fornwald

Inhibition of Transforming Growth Factor (TGF)-β1–Induced Extracellular Matrix with a Novel Inhibitor of the TGF-β Type I Receptor Kinase Activity: SB-431542

Nicholas J. Laping, Eugene T. Grygielko, Anil Mathur et al. · Molecular Pharmacology · 2002 · 647 citations

Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small molecules

Celia P. Briscoe, Andrew J. Peat, Stephen C. McKeown et al. · British Journal of Pharmacology · 2006 · 395 citations · Full text

Cellular Physiology, Insulin Signaling, Molecular Pharmacology +20

Identification of the residues in human CD4 critical for the binding of HIV

James Arthos, Keith C. Deen, Margery A. Chaikin et al. · Cell · 1989 · 355 citations

Human Retrovirus, Immunology, Antiviral Response +6

Identification of Novel Inhibitors of the Transforming Growth Factor β1 (TGF-β1) Type 1 Receptor (ALK5)

James F. Callahan, Joelle L. Burgess, James A. Fornwald et al. · Journal of Medicinal Chemistry · 2002 · 309 citations · Full text

Drug Target, Pharmacotherapy, Cell Growth +18

The human polo-like kinase, PLK, regulates cdc2/cyclin B through phosphorylation and activation of the cdc25C phosphatase

Amy Roshak, Elizabeth A. Capper, Christina S. Imburgia et al. · Cellular Signalling · 2000 · 213 citations

Signal Transduction, Cdc25c Phosphatase, Signaling Pathway +11